Globavir
Los Altos
About Globavir
Globavir was founded in 2011 by Dr. Shalabh Gupta. Globavir was built on multiple licenses from Stanford University from multiple different professors and multiple different departments. In 2014, Globavir acquired BioCycive in all stock deal, and BioCycive became a wholly owned subsidiary of Globavir. In 2015, BioCycive's lead program was partnered with Sorrento Therapeutics. In 2016, Globavir partnered its diagnostic test with Bio-Rad.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $11.5M
- Funding stage: Early Stage Venture
- Last round: Series B (May 2018)
- Website: globavir.com
- Phone: +116503514495
Industries & Categories
Biotechnology, Health Care, Health Diagnostics, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/globavir-142885 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.